Paid Clinical Trials in Tennessee

Tennessee has 2,076 paid clinical trials enrolling now across cities including Nashville, Memphis and Knoxville. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Tennessee include Vanderbilt University Medical Center and St. Jude Children's Research Hospital, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,847 clinical trials

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

for Cancer

Sites in Nashville +14 more locations

Sponsor: Krystal Biotech, Inc.

Sex: All·Age: 18+

Code: NCT05970497·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

Sites in Nashville +6 more locations

Sponsor: Theralase® Technologies Inc.

Sex: All·Age: 18+

Code: NCT03945162·Phase 2·Recruiting·Listed May 2019

Apply to this trial

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for Locally Advanced Solid Tumor

Sites in Nashville +18 more locations

Sponsor: Nuvalent Inc.

Sex: All·Age: 12+

Code: NCT05118789·Phase 1, Phase 2·Recruiting·Listed Nov 2021

Apply to this trial

Total Shoulder Arthroplasty Multi-Center Registry

for Shoulder Arthroplasty

Sites in Germantown +14 more locations

Sponsor: Arthrex, Inc.

Sex: All·Age: 18 - 100

Code: NCT03511586·Recruiting·Listed Apr 2018

Apply to this trial

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumors

Sites in Nashville +12 more locations

Sponsor: DynamiCure Biotechnology

Sex: All·Age: 18+

Code: NCT05785754·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

A Study of RSLV-132 in Females With Sjögren's Disease

for Primary Sjögren Syndrome

Sites in Nashville +23 more locations

Sponsor: Resolve Therapeutics

Sex: Female·Age: 18 - 75

Code: NCT06440525·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Nashville +17 more locations

Sponsor: Marengo Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05592626·Phase 1, Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

for Solid Tumor

Sites in Nashville +19 more locations

Sponsor: Corbus Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT06603844·Phase 1, Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

for Locally Advanced Solid Tumor

Sites in Nashville +13 more locations

Sponsor: Tango Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05732831·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

Post-Market Study to Assess iTind Safety in Comparison to UroLift

for Benign Prostatic Hyperplasia (BPH)

Sites in Germantown +12 more locations

Sponsor: Olympus Corporation of the Americas

Sex: Male·Age: 50+

Code: NCT04757116·Recruiting·Listed Feb 2021

Apply to this trial

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for Solid Tumor, Adult

Sites in Nashville +12 more locations

Sponsor: GV20 Therapeutics

Sex: All·Age: 18+

Code: NCT05669430·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

Desara ® One Single Incision Sling 522 Study

for Stress Urinary Incontinence

Sites in Franklin +14 more locations

Sponsor: Caldera Medical, Inc.

Sex: Female·Age: 18+

Code: NCT04772131·Recruiting·Listed Feb 2021

Apply to this trial

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

for Acute Kidney Injury

Sites in Nashville +14 more locations

Sponsor: SeaStar Medical

Sex: All·Age: Up to 22

Code: NCT06517810·Recruiting·Listed Jul 2024

Apply to this trial

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Nashville +13 more locations

Sponsor: Fate Therapeutics

Sex: All·Age: 18+

Code: NCT06241456·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

for Tachycardia, Ventricular

Sites in Nashville +10 more locations

Sponsor: Varian, a Siemens Healthineers Company

Sex: All·Age: 18+

Code: NCT05765175·Recruiting·Listed Mar 2023

Apply to this trial

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for Chronic Lymphocytic Leukemia (CLL)

Sites in Nashville +6 more locations

Sponsor: Nurix Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT04830137·Phase 1·Recruiting·Listed Apr 2021

Apply to this trial

Pivotal Study for the Cardiac Performance System (CPS)

for Cardiovascular Diseases

Sites in Germantown +9 more locations

Sponsor: Sensydia Corporation

Sex: All·Age: 18+

Code: NCT06870591·Recruiting·Listed Mar 2025

Apply to this trial

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

for Heart Transplant

Sites in Nashville +13 more locations

Sponsor: XVIVO Perfusion

Sex: All·Age: 18+

Code: NCT06895070·Recruiting·Listed Mar 2025

Apply to this trial

A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

for Adenovirus Infections

Sites in Memphis +8 more locations

Sponsor: SymBio Pharmaceuticals

Sex: All·Age: 2 Months+

Code: NCT04706923·Phase 2·Recruiting·Listed Jan 2021

Apply to this trial

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for Brain Cancer

Sites in Nashville, Memphis +14 more locations

Sponsor: Adela, Inc

Sex: All·Age: 40+·Accepts healthy volunteers

Code: NCT05366881·Recruiting·Listed May 2022

Apply to this trial

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

for B-cell Acute Lymphoblastic Leukemia

Sites in Nashville +12 more locations

Sponsor: Cellectis S.A.

Sex: All·Age: 15 - 50

Code: NCT04150497·Phase 1, Phase 2·Recruiting·Listed Nov 2019

Apply to this trial

Study With Phage for CF Subjects With Pseudomonas Lung Infection

for Chronic Pseudomonas Aeruginosa Infection

Sites in Nashville +13 more locations

Sponsor: BiomX Ltd

Sex: All·Age: 18+

Code: NCT06998043·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for Leukemia

Sites in Nashville +12 more locations

Sponsor: BlossomHill Therapeutics

Sex: All·Age: 18+

Code: NCT06501196·Phase 1·Recruiting·Listed Jul 2024

Apply to this trial

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

for Coronary Artery Disease

Sites in Nashville +16 more locations

Sponsor: Kardion Inc

Sex: All·Age: 18 - 90

Code: NCT06445608·Recruiting·Listed Jun 2024

Apply to this trial

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

for Intestinal Failure Associated Liver Disease

Sites in Nashville +12 more locations

Sponsor: NorthSea Therapeutics B.V.

Sex: All·Age: 16+

Code: NCT05919680·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

for NHL

Sites in Nashville +8 more locations

Sponsor: Indapta Therapeutics, INC.

Sex: All·Age: 18+

Code: NCT06119685·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

for Small Cell Lung Cancer

Sites in Nashville +10 more locations

Sponsor: Chipscreen Biosciences, Ltd.

Sex: All·Age: 18+

Code: NCT05271292·Phase 1, Phase 2·Recruiting·Listed Mar 2022

Apply to this trial

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

for Diabetic Foot Ulcer

Sites in Jackson +9 more locations

Sponsor: Energenesis Biomedical Co., Ltd.

Sex: All·Age: 18+

Code: NCT05930210·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

for Parenteral Nutrition Associated Liver Disease (PNALD)

Sites in Nashville +9 more locations

Sponsor: Fresenius Kabi

Sex: All·Age: 1 Day - 17

Code: NCT06274788·Recruiting·Listed Feb 2024

Apply to this trial

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

for Acute Myeloid Leukemia, in Relapse

Drug: Iadademstat

Sites in Nashville +12 more locations

Sponsor: Oryzon Genomics S.A.

Sex: All·Age: 18+

Code: NCT05546580·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS

for Respiratory Distress Syndrome (Neonatal)

Sites in Jackson +9 more locations

Sponsor: ONY

Sex: All·Age: 29 Weeks - 36 Weeks

Code: NCT05960929·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

for Migraine

Sites in Nashville +5 more locations

Sponsor: Aspeya, Inc.

Sex: All·Age: 18 - 65

Code: NCT07646613·Phase 2·Recruiting·Listed Jun 15, 2026

Apply to this trial

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

for Follicular Lymphoma

Drug: Rituximab

1 location in Nashville

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07634471·Phase 2, Phase 3·Recruiting·Listed Jun 8, 2026

Apply to this trial

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

for Lipoprotein(a)

Sites in Kingsport +11 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07614984·Phase 2·Recruiting·Listed May 2026

Apply to this trial

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

for Advanced Solid Cancer

Sites in Nashville +3 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07607678·Phase 1·Recruiting·Listed May 2026

Apply to this trial

Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer

for Triple Negative Breast Cancer (TNBC)

Sites in Nashville +1 more location

Sponsor: Immunomic Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT07652242·Phase 1·Recruiting·Listed Jun 17, 2026

Apply to this trial

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for Locally Advanced (Unresectable) or Metastatic Solid Tumors

Sites in Nashville +7 more locations

Sponsor: NEOK Bio, Inc.

Sex: All·Age: 18+

Code: NCT07612189·Phase 1·Recruiting·Listed May 2026

Apply to this trial

A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

for Locally Advanced (Unresectable) or Metastatic Solid Tumors

Sites in Nashville +7 more locations

Sponsor: NEOK Bio, Inc.

Sex: All·Age: 18+

Code: NCT07612176·Phase 1·Recruiting·Listed May 2026

Apply to this trial

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

for HR+ HER2- Breast Cancer

Sites in Nashville +6 more locations

Sponsor: Faeth Therapeutics

Sex: All·Age: 18+

Code: NCT07558733·Phase 1, Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

for Advanced NRAS-Mutant Melanoma

Sites in Nashville +8 more locations

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07584226·Phase 1·Recruiting·Listed May 2026

Apply to this trial